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Abstract
Background: Late-Onset Bloodstream Infections (LO-BSI) continue to be one of the most important complications
associated with hospitalization of infants born with very low birth weight (VLBW). The aims of this study were to
assess the epidemiology of LO-BSI together with the risk factors and the distribution of causative pathogens at six
Polish neonatal intensive care units that participated in the Polish Neonatology Surveillance Network from January
1, 2009 to December 31, 2011.
Methods: The surveillance covered 1,695 infants whose birth weights were <1501 grams (VLBW) in whom LO-BSI
was diagnosed >72 hours after delivery. Case LO-BSI patients were defined according to NeoKISS.
Results: Four hundred twenty seven episodes of LO-BSI were diagnosed with a frequency of 25.3% and an
incidence density of 6.7/1000 patient-days (pds). Results of our multivariate analysis demonstrated that surgical
procedures and lower gestational age were significantly associated with the risk of LO-BSI. Intravascular catheters
were used in infants with LO-BSI significantly more frequently and/or for longer duration: Central venous cathters
(CVC) (OR 1.29) and Peripheral venous catheters (PVC) (OR 2.8), as well as, the total duration of total parenteral
nutrition (13 vs. 29 days; OR 1.81). Occurrence of LO-BSI was significantly associated with increased the length of
mechanical ventilation (MV) (OR 2.65) or the continuous positive airway pressure (CPAP) (OR 2.51), as well as, the
duration of antibiotic use (OR 2.98). The occurrence of more than one infection was observed frequently (OR 9.2)
with VLBW with LO-BSI. Microorganisms isolated in infants with LO-BSI were dominated by Gram-positive cocci, and
predominantly by coagulase-negative staphylococci (62.5%).
Conclusions: Independent risk factor for LO-BSI in VLBV infants are: low gestational age and requirement for
surgery. The incidence rates of LO-BSI especially CVC-BSI were higher in the Polish NICUs surveillance than those of
other national networks, similar to the central- and peripheral utilization ratio.
Background
Late-Onset Bloodstream Infections (LO-BSI) continue as
a critical complication associated with hospitalization of
very low birth weight (VLBW) infants. LO-BSI contributes
to morbidity, mortality, and other long-term adverse out-
comes [1-5]. Surveillance of these infants, especially blood
stream infections (BSI) was introduced in intensive care
units in Poland [6,7] however, the epidemiology of these
infections has not previously been collected systematically
in Polish VLBW infants.
The epidemiology of infections among neonatal inten-
sive care units (NICUs) in the USA has been explor-
ed through the National Healthcare Safety Network
(NHSN) system of the Centers for Disease Control and
Prevention (CDC); however, limited information has
been available from the European countries. The big-
gest one, German “Krankenhaus-Infections-Surveillance-
System”, NeoKISS (http://www.nrz-hygiene.de/en/surveillance/
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hospital-infection-surveillance-system) began in January
2000 as a prospective surveillance system for VLBW in-
fants [8,9]. The similar surveillance systems have been im-
plemented in France: Epidemiologie des Petits Ages
Gestationnels, EPIPAGE study [10] and in the United
Kingdom: the Neonatal Infection Surveillance Network,
neonIN [11].
The aim of this study was to assess the epidemiologic
factors and microbiological spectrum of primary LO-
BSIs associated with or without intravascular devices
together with identification of risk factors and the distri-
bution of causative pathogens. A second aim was to im-
plement uniform definitions, specimen acquisition, and
culturing techniques for infection surveillance: continu-
ous, systematic collection, analysis and interpretation of
health-related and infections data.
Methods
Utilization of data collected in the Polish Neonatology
Surveillance Network (PNSN) for the scientific purpose
was approved by the Bioethics Committee of Jagiellonian
University Medical College – no. KBET/221/B/2011.
Continuous prospective target surveillance of infec-
tions was conducted from 1/1/2009 through 12/31/2011
at six Polish NICUs (only teaching hospitals) which par-
ticipated in PNSN. These tertiary NICUs provided care
for 20% of all VLBW infants born in Poland annually.
The surveillance included infants hospitalized in these
NICUs whose birth weights were <1501 grams (VLBW)
at birth until they achieved a weight of 1800 grams or
died. The general fatality case rate was 16.3%. The fatal-
ity case rate in subgroup of infants with a birth weight
<500 grams was 75%; thus on 1 infant reached a weight
of >1800 grams with a LO-BSI, and 3 were transferred
to other units and were not further included in the
surveillance within the PNSN. All VLBW infants of sus-
pected or documented infected were subject to registra-
tion regardless of the time of occurrence according to
criteria of Gastmeier et al. (see Appendix 1) when they
had clinical signs of a bloodstream infection (BSI) [8].
Pneumonia and necrotizing enterocolitis were defined
also according to criteria of Gastmeier et al. [8]. LO-BSI
was defined when diagnosed >72 hours after delivery.
Clinical sepsis represented an infant where signs of
infection existed but on blood culture a causative organ-
ism was not identified. Central venous catheter (CVC)-
associated BSI (CVC-BSI) and peripheral intravenous
catheter (PVC) associated BSI (PVC-BSI) were infections
associated with the use of a central or peripheral venous
catheter within the preceding 48 hours prior to the onset
of the infection [8,12]. The CVC utilization rate was
0.45 and the PVC utilization rates was 0.16 (calculated
by dividing the number of days of CVC/PVC by the total
number of patient days).
A surgical procedure was defined as surgery per-
formed within an operating theater except for insertion
of CVC involving a surgical incision for tissue removal
or repair or to treat a surgical condition. The analysis
was performed in infants prior their attaining a weight
of 1800 grams in all cases. In the analysis of the relation-
ship between LO-BSI and need for surgery, infants were
included when the initial signs were observed between 3
to 30 days after operative intervention. Infants with
more than one episode of infection were included; how-
ever, the addition of or change in pathogen was not ne-
cessarily indicative of a new episode of infection.
All blood specimens of at least 1 milliliter were
injected into an aerobic blood culture bottle (Bactec Plus
26 Aerobic; BD Microbiology Systems) and cultured on
MacConkey agar, horse blood agar (at 37 degrees C,
each for 24 h) and Sabourand agar (at 37 degrees C for
38 hours. The isolates were characterized using bio-
chemical tests, bioMerieux identification kit API system
(bioMerieux, France).
Statistical methods
These data were not subject to external validation (by
researchers from other/external centers) and approxi-
mately 5% of the records were incomplete. Analysis of
the impact of selected factors for the risk of LO-BSI was
based on the group of infants who survived until the
third day or longer. For the evaluation of the differences
between the averages for the examined groups of infants,
a one way analysis of variance (ANOVA) with the least
significant difference test and Tukey’s test were applied.
For the assessment of the frequency of infections in vari-
ous groups of infants the chi-square test of independ-
ence was used.
A logistic regression model was used to initially exam-
ine whether there were observations with missing data
or divergent data. The elimination of outliers for each
variable was quantified based on box graphs, and we cal-
culated measures of association using a model of select-
ing the explanatory variables intuitively understanding
that each variable can have an effect on the dependent
variable. The dependent variable was the dichotomous
variable: the occurrence or non-occurrence of LO-BSI.
Thereafter, a formal model of logistic regression was
constituted to estimate the parameters using the quasi-
Newton method. Analysis of the individual p-values
allowed us to reject variables that were statistically insig-
nificant. Before deciding to remove a variable, a logistic
regression was performed separately for each factor
(birth weight, gestational age, or requirement for sur-
gery). The Clinical Risk Index for Babies (CRIB) score,
and Apgar 1 and 5 minutes scores were also included in
the logistic model. The odds ratio (OR) was used to
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determine the effect of a specific factor to increase the
likelihood of LO-BSI.
A generalized linear model (GLZ) was applied to assess
the significance of differences between Staphylococcus
aureus, the coagulase-negative staphylocci (CNS), Entero-
bacteriaceae and other microorganism infection, and birth
weight, gestational age, duration of hospitalization prior
to the date of onset of the initial clinical sign or used
of devices: CVC, PVC, mechanical ventilation (MV),
and/or continuous positive airway pressure (CPAP). These
models were evaluated separately for each bacterial
groups. As the dependent variable was dichotomous, the
binominal distribution was used. The predictors used in
the model were continuous (birth weight, gestational age,
duration of hospitalization), as well as, the categorical var-
iables (use of CVC, PVC, MV and/or CPAP). Including
such a set of variables in this model demands using the
logit-linked function. Calculations were performed with
the application of the open source library SciPy. A multi-
variate analysis of the influence of the risk factors on
CVC-BSI identification was conducted using a classifica-
tion tree learner [13,14] (Orange Biolab). A p <0.05 was
considered statistically significant.
Our data were compared with NeoKISS surveillance
system in Germany. In this analysis, data from one of
six centers were not used because information about
CVC and/or PVC catheterization, MV and/or CPAP
was incomplete. NeoKISS data were chosen for com-
parison to the data from the PNSN owing to the me-
ticulous research methods employed in this surveillance
program.
Results
Description of the population
There were 1,695 newborns included in our surveillance
of whom 1,243 who survived >72 hrs. This group was
composed of 462 (27.3%) of extremely low birth weight in-
fants with a birth weight < = 750gms, 313 (18.5%) infants
with a birth weight from 751 to 999 gm, and 920 (54.3%)
infants with birth weight ranging from 1000–1500 gm.
Among these 1,234 infants, 164 (9.7%) underwent surgical
procedures. The most common surgical procedure was
closure of the patent ductus arteriosus (PDA) which rep-
resented 48.4% of all surgical procedures.
Late-onset bloodstream infections
There were 427 episodes of LO-BSI diagnosed represent-
ing an incidence density of 6.7/1000 patient days (pds),
including 46 cases of clinical sepsis were observed
(10.7% of all LO-BSI). The onset of clinical signs of LO-
BSI occurred an average of 15 days after birth (SD
14.3 days; median 11 days). Mean gestational age was
28 weeks (median 27 weeks) and the mean birth weight
was 1100 grams (median 880 grams). Among infants
with LO-BSI birth weights were significantly lower than
in the group of newborns not having LO-BSI (Table 1).
The incidence of LO-BSI among infants within various
birth weight categories were significantly different. The
highest incidence rate (compared to infants with higher
birth weight) was confirmed in the infants with birth
weights <750 grams: 44.6% vs. 27.1% (OR 2.36; 95% CI
1.60-3.47). Results of the multivariate analysis found that
low gestational age (p = 0.002; OR 3.9; 95% CI 2.99-5.12)
and requirement for surgery (p<0.001; OR 1.8 95% CI
1.32-2.56) were significantly associated with risk of LO-
BSI (up to 30 days after surgery) and others (Table 2).
Those infants with LO-BSI were more frequently vul-
nerable to other infection such as pneumonia (OR 2.13;
95% CI 1.52-2.97) or necrotizing enterocolitis (OR 1.55;
95% CI 1.00-2.44). The occurrence of more than one
infection was observed frequently (OR 9.2; 95% CI 6.05-
13.98). In the group of infants with signs of LO-BSI, we
did not observe an increased mortality rate; however,
early mortality associated with LO-BSI occurred usu-
ally < 7 days after the occurrence of the initial signs of
LO-BSI was 7.5%.
The requirement for mechanical ventilation (OR 2.64
95% CI 1.96-3.55) or the use of CPAP (OR 2.51; 95% CI
1.83-3.44) were significantly more frequent among
VLBW infants with LO-BSI. Analysis showed no associ-
ation between the studied NICUs and the incidence rate
of LO-BSI.
Central and peripheral venous catheter-associated blood-
stream infections
The CVC-BSI incidence rate was 8.6/1000 CVCdays,
and the PVC-BSI incidence was: 10.5/1000 PVCdays.
The incidence rate of PVC-BSI and CVC-BSI in infants
with birthweights of 1000–1499 grams was significantly
higher than in other groups of infants (RR 1.9, p<0.001).
In infants with LO-BSI, compared to infants without
LO-BSI, the catheters were used significantly more fre-
quently and/or for a longer time: CVC (OR 1.2931, 95%
CI 0.93-1.79) and PVC (OR 2.8031, 95% CI 2.06-3.81)
(Table 1). Short-term use of PVC – up to 10 days – did
not influence on the risk of LO-BSI.
Also, in infants with LO-BSI compared to infants with-
out LO-BSI, total parenteral nutrition was prescribed
significantly more frequently (OR 1.813, 95% CI 1.25-
2.64), and/or for a longer duration, average: 13 vs.
29 days (over 16 days, OR 4.3489, 95% CI 3.17-5.96).
Microbial aetiology of the LO-BSI
Gram-positive cocci constituted 77% of the isolated patho-
gens from CVC-BSI. The largest group was coagulase-
negative staphylococci (CNS) and Staphylococcus aureus.
The dominant species among group of the CNS isolates
were S. epidermidis (62.5%), then S. haemolityicus (20%),
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S. warneri (7.5%), S. hominis (5%), S. xylosus (2.5%) and
S. capitis (2.5%).
Gram-negative rods were isolated more often in PVC-
BSI than in CVC-BSI (Table 3), especially, Klebsiella spp
which were the second most common microorganisms
in PVC-BSI. Infections caused by yeast-like fungi consti-
tuted 3.8% of all the BSI cases and there were no other
fungal infections.
There was no relationship between the bacterial eti-
ology of LO-BSI, and the following: birthweight, gesta-
tional age, length of hospitalisation before the date of
first signs and the use of devices analysed separately with
one-factor statistical techniques.
Discussion
Our results of LO-BSI are the first to be reported by
the Polish Neonatology Surveillance Network (PNSN)
and from Central Europe (except Neo-KISS) based
on a national program for infection surveillance and
control among NICUs. Our previous report on this
population within the PNSN focused on early onset
infection [15].
Table 1 The characteristics of infants with and without symptoms of LO-BSI, who survived to the third day and/or later
Infant’s LO-BSI (−) [N = 816] Infant’s LO-BSI (+) [N = 427] Statistically
significant
P-value
Characteristics of patients average; 95% CI
Gestational age [weeks] 29 (28; 29) 27 (27; 28) <0.001
Gestational age infants who required surgery [weeks] 26 (26; 27) 25 (28; 29) 0.002
Gestational age infants who did not required surgery [week] 29 (29; 29) 28 (27; 28) <0.001
Birth weight [grams] 1 114 (1 087; 1 141) 947 (920; 974) <0.001
CVC [days] 15 (14; 16) 31 (27; 34) <0.001
PVC [days] 9 (8; 10) 18 (16; 21) <0.001
Mechanical ventilation [days] 12 (10; 13) 26 (22; 30) <0.001
CPAP [days] 9 (8; 9) 16 (14; 17) <0.001
Total parenteral nutrition [days] 13 (12; 14) 29 (27; 32) <0.001
surgery in infancy*[No./%] 87 10.7 77 18.0 <0.001
Completion of the surveillance
Death of the patient [No./%] 67 8.2 32 7.5 0.4
Transfer [No./%] 101 12.4 48 11.2 0.2
Body weight gain [No./%] 646 79.2 345 80.8 0.9
* up to 30 days after surgery; CI – confidence interval; LO-BSI, Late-Onset Bloodstream Infections; PROM, premature rupture of membranes; CVC, central venous
catheter; PVC, peripheral intravenous catheter; CPAP, continuous nasal positive airway pressure.
Table 2 Crude and adjusted odds ratio (OR) and 95% confidence intervals (95% CI) for nevborns with and without
symptoms of LO-BSI (late onset bloodstream infections), who survived to the third day and/or later (2009–2011)
Infant’s LO-BSI (−) [N = 816] Infant’s LO-BSI (+) [N = 427]
Characteristics of patients crude OR 95% CI adjusted* OR 95% CI
Gestational age <28 week 3.9 2.99-5.13 71.808 71.57-72.05
Birth weight < 750 grams 2.362 1.60-3.48 3.732 3.45-4.01
Chorioamnionitis 1.404 0.80-2.45 1.185 0.96-1.42
PROM 1.079 0.78-1.48 3.343 2.97-3.72
CVC 1.293 0.93-1.79 2.886 2.49-3.27
PVC 2.803 2.06-3.81 1.523 1.14-1.91
Mechanical ventilation 2.645 1.97-3.56 12.642 12.31-12.98
CPAP 2.514 1.83-3.44 2.927 2.62-3.24
Total parenteral nutrition 1.813 1.25-2.64 2.912 2.72-3.11
Surgical procedures 1.882 1.28-2.77 2.912 2.72-3.11
Adjusted for birth weight; gestational age; surgery in infancy; Clinical Risk Index for Babies, CRIB; score, Apgar 1- and 5-minute scores.
PROM, premature rupture of membranes, CVC, central venous catheter; PVC, peripheral intravenous catheter; CPAP continuous nasal positive airway pressure.
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LO-BSI incidence in our population are lower than
those observed in other national surveillance projects.
For example, in a report from the Netherlands the inci-
dence in their groups of 742 VLBW infants was 14.9/
1000 pds [16], and in the German NeoKISS study in
their first year of reporting their incidence was 8.3/1000
pdys that included 303 VLBW infants. In the USA, the
reported incidence for infants born at 28 weeks gestation
or earlier was: 36% [1], while in Israel a 39% rate [17].
Our data focusing on infections associated with vascu-
lar lines do differ substantially from those published by
other centers e.g. NeoKISS [18]. The CVC-BSI in our
total study population was greater than 8.6/1000 CVC
days, while in the NeoKISS surveillance it was 13.8/1000
CVC days during the initial year of reporting. However,
in our population we did not identify CVC-BSI in ex-
tremely low birthweight infants (ELBW) infants <499
grams, because of their high fatality rate. However, in
the NeoKISS surveillance program this group had the
highest risk of CVC associated infections, as well as,
PVC-BSI. Unfortunately, this severe morbidity in Polish
NICUs had the highest incidence of both CVC-BSI and
PVC-BSI among infants with birth weights <1000 gms.
Our surveillance found a 60-80% increase over than re-
ported by the NeoKISS program [9], and higher than
that reported by Sengupta et al. [18].
Therefore, our results indicate the need to reduce the
risk of infections associated with vascular line in Polish
NICUs; Gastmeier et. al. found that after 3 years of sur-
veillance: German NICUs reported a significant reduction
in the of CVC-BSI infants from 13.8 to 10.6 cases/1000
CVC days (RR. 0.77, p=0.008) [9,19]. The German experi-
ence suggests that participation in ongoing surveillance of
nosocomial infections in NICUs, requiring individual
units to provide data may lead to a reduction in BSI rates
when there is through participation in a national surveil-
lance system with feedback and quality improvement [19].
Historical data from the American National Healthcare
Surveillance Network [20] from 1992–2001 found that
CVC- BSI was 11.3/1000 CVCdays among infants with
birth weights <750 gm and 6.9/1000 CVCdays among in-
fants 1001–1500 gm. However, the most current data
from this surveillance network reported a 4 fold reduction
in catheter associated infections in 2012 [21], and similar
to rates reported from Canada [22].
The next important issue: our data also indicate a high
CVC utilization rate in Polish NICUs: almost twice as
likely and often (or: for a longer duration) than in the
German NICUs [9].
Gram positive cocci organisms were the dominant mi-
croorganisms isolated in LO-BSI, including CNS, and es-
pecially associated with catheter associated infections.
The predominance of these organisms were associated
with catheter related LO-BSI in the USA [18], Japan
[23], Taiwan [24] and Israel [25]. Freeman et al. first de-
scribed dominance of CNS with increasing survival of
ELBW infants in the 1970s [26] with longer duration of
use of intravenous catheters [26]; fortunately, LO –BSI
with CNS have not been characterized by an increased
mortality [26,27].
Table 3 The occurence of the pathogens of the late-onset BSI, diagnosed >72 hours after delivery (2009-2011)
CVC-BSI [N = 208] PVC-BSI [N = 74] All LO-BSI Fatal cases No./
fatal care rateNo/%
Gram-positive microorganisms 180 81.8 54 72.0 304 77.0
CNS 143 65.0 41 54.7 247 62.5 6 / 2.4%
Staphylococcus aureus 18 8.2 7 9.3 31 7.8 1 / 3.2%
Enterococcus spp./Streptococcus spp 19 8.6 6 8.0 26 6.6 1 / 3.8%
Gram-negative microorganisms 32 14.5 17 22.7 73 18.5
Escherichia coli 12 5.5 5 6.7 26 6.6 4 / 15.4%
Klebsiella spp. 11 5.0 9 12.0 27 6.8 3 / 11.1%
Enterobacter spp. 3 1.4 2 2.7 8 2.0
Enterobacteriaceae other 1 0.5 1 1.3 4 1.0 2 / 50%
Acinetobacter baumanii 0 0.0 1 1.3 3 0.8
Pseudomonas aeruginosa 5 2.3 0 0.0 5 1.3 4 / 80%
Yeats 8 3,6 3 4.0 15 3.8 1 / 6.7%
Others 0 0.0 1 1.3 3 0.8
Total* 220 100.0 76 100.0 395 100.0
Legend:* Total microbial etiological factors is greater than the number of LO-BSI confirmed microbiologically by a mixed culture found in several infections.
LO-BSI – late onset bloodstream infections, CVC-BSI – Central Venous Catheter-Associated BSI, PVC-BSI Peripheral Venous Catheter-Associated BSI;
CNS – Coagulase-negative staphylococci.
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Gram-negative rod infections were mostly observed
among LO-BSI in patients without prolonged use of vas-
cular lines; however, we found a lower frequency of
gram-negative rod infections than have been reported in
the UK [11], Taiwan [24], Germany [9], or U.S.A. [28]. In
our surveillance yeast LO-BSI infections were found in
3.8% of infants <1000 gm and lower than that reported
by Greenberg [3,29], but higher than that reported by
Mazoni (1.4%) [30].
VLBW infants constitute a small group of patients
undergoing surgical procedures. The literature on postsur-
gical in VLBW newborns has not been widely publicized.
Many researchers studying the epidemiology of nosoco-
mial infections exclude the group of VLBW infants under-
going surgery citing the diversity of this specific population
that would interfere with more generalizable knowledge.
In our studies the dominant problem were LO-BSI associ-
ated with infant surgery. In a publication from the U.S.,
risk factors for infections are late PDA closure procedures
(6 or more days after diagnosis) and very low birthweight
[31]. Importantly, the number of PDA closures (81 in 1243
infants who survived > 72 hrs) is consistent with the report
by Evans, who found about 10% of infants born before
27 weeks (and 3% of infants born at 27–29 weeks) required
PDA surgical ligation [32]. Small number reports about
the state of post-operative infants is insufficient [33,34].
A limitation of this study is that there were not inde-
pendent auditors at each site to valid submitted data. Fur-
thermore, VLBW infants frequently have multisystem
diseases resulting from immaturity such as respiratory dis-
tress syndrome and apnea or bradycardia episodes that re-
quire interventions with medical devices (MV or CPAP).
For the first weeks of life limited enteral nutrition must be
supplement with parenteral nutrition provided through
vascular catheters that also increase their risk for infection.
Infant born after maternal chorioamnionitis may receive
initial antibiotic therapy that is of insufficient duration to
treat neonatal sepsis, or may not have sufficient spectrum
of coverage to treat organisms more prevalent in LO-BSI.
As a group VLBW infants are immunologically "imma-
ture" with limited and variable transplacental antibody
transfer from their mothers further increasing their risk
for LO-BSI. Nonetheless by introducing common defini-
tions, technique and quantity of blood specimen acquisi-
tion, and uniform microbiological techniques at each
center in the PNSN, our surveillance provide for baseline
data for quality improvement initiatives. Our focus will be
to reduce the duration of CVC and PVC use to minimize
the risk of LO-BSI in this population, and to meticulously
care for these catheters once inserted.
Conclusions
In VLBW infants in whom use of CPAP or mechanical
ventilation is nearly universal and in whom the presence
of vascular catheters is nearly routine, we found that
coagulase-negative staphylocci were the most common
cause of LO-BSI. While rates of LO-BSI especially asso-
ciated with CVC- BSI were higher in the Polish NICUs
than those of other national networks, we now have evi-
dence to inform the neonatologist into more precise
selection of antimicrobial coverage when an LO-BSI is
suspected. Furthermore, based on these findings it is
necessary to implement a national program of infectious
disease monitoring while promoting the shortest dur-
ation of CVC and PVC use as possible. There is also an
ongoing need to monitor all VLBW undergoing surgery
in the neonatal period for post-surgical infections to
reduce the LO-BSI incidence.
Appendix 1
Definitions of infections in infants born with very low
birth weight, according to [8]:
1. Bloodstream infection (BSI):
 Presence of at least two of the following: temper-
ature >38°C or <36.5°C or temperature insta-
bility, tachycardia or bradycardia, apnea, prolonged
capillary refill, metabolic acidosis, hypoglycemia,
other signs of bloodstream infections such as
lethargy;
and
 Physician already having instituted treatment
for sepsis for at least five days; blood culture
not done or no organism detected in blood;
no apparent infection at another site (clinical
sepsis)
or
 Recognized pathogen cultured from one or more
blood cultures or cerebrospinal fluid and no
coagulase-negative staphylococci (pathogen
not related to an infection at another site) or
coagulase-negative staphylococci isolated from
at least one blood culture or intravascular
line and one of the following: C-reactive pro-
tein >2.0 mg/dL, immature/total neutrophil
ratio (I/T ratio) >0.2, leukocytes <5000/μl,
platelets <10000/μl.
2. Pneumonia:
 one of the following criteria: chest radiography
showing new or progressive infiltrates, consol-
idation or fluid in the lobar fissures/pleura, and
 worsening of gas exchange, and
 four or more of the following signs: worsening of
gas exchange, temperature instability, new onset
or increasing bradycardia (<80/min) or new
onset or increasing tachycardia (>200/min), new
onset or increasing tachypnea (.60/min) or
apnea, (>20 s), new onset or increasing dyspnea
Wójkowska-Mach et al. BMC Infectious Diseases 2014, 14:339 Page 6 of 8
http://www.biomedcentral.com/1471-2334/14/339
(retractions, nasal flaring, grunting, increasing
production of respiratory secretions and increasing
need for suction, purulent tracheal secretions,
isolation of a pathogen in respiratory secretions, C-
reactive protein2.0 mg/dl, immature/total ratio of
neutrophil blood cells 0.2 or more)
3. Necrotising enterocolitis (NEC):
 Presence of two of the following clinical signs and
symptoms without any other recognized reason
at least two of the following signs: vomiting,
abdominal distention, pre-feeding residuals, red-
ness of flanks, persistent microscopic or gross
blood in stools;
 and at least one of the following criteria: pneumo-
peritoneum, pneumatosis intestinalis, unchanging
‘rigid’ loops of small bowel; or histological evidence
of NEC.
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